Effect of antenatal betamethasone administration on placental vascular resistance
- 1 April 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 353 (9162) , 1404-1407
- https://doi.org/10.1016/s0140-6736(98)08229-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Pathology and clinical implications of abnormal umbilical artery Doppler waveformsUltrasound in Obstetrics & Gynecology, 1997
- Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous treeAmerican Journal of Obstetrics and Gynecology, 1996
- Current topic: The placental corticotrophin-releasing hormone-adrenocorticotrophin axisPlacenta, 1995
- Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical arteryThe Lancet, 1994
- Update of Growth Percentiles for Infants Born in an Australian PopulationAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1994
- Antenatal screening for intrauterine growth retardation with umbilical artery Doppler ultrasonography.BMJ, 1989
- Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta.Proceedings of the National Academy of Sciences, 1988
- Doppler ultrasound waveform indices: A/B ratio, pulsatility index and Pourcelot ratioBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Umbilical artery flow velocity waveforms and the placental vascular bedAmerican Journal of Obstetrics and Gynecology, 1987
- Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlationBJOG: An International Journal of Obstetrics and Gynaecology, 1985